Journal: Archives of pharmacal research

Article Title: Prunin is a highly potent flavonoid from Prunus davidiana stems that inhibits protein tyrosine phosphatase 1B and stimulates glucose uptake in insulin-resistant HepG2 cells.

PMID/MRN: 27798765

Publication Date: 2016-Oct-31

Abstract:

Prunin is the main flavonoid in Prunus davidiana stems and improves hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats. The aim of this study was to investigate the in vitro anti-diabetic potential of prunin via the inhibition of protein tyrosine phosphatase 1B (PTP1B), ?-glucosidase, peroxynitrite (ONOO - )-mediated tyrosine nitration, and stimulation of glucose uptake in insulin-resistant hepatocytes. In addition, a molecular docking simulation was performed to predict specific prunin binding modes during PTP1B inhibition. Prunin showed strong inhibitory activity against PTP1B, with an IC 50 value of 5.5ʱÊ0.29ʵM, and significant inhibitory activity against ?-glucosidase, with an IC 50 value of 317ʱÊ2.12ʵM. Moreover, a kinetics study revealed that prunin inhibited PTP1B (K i Ê=Ê8.66) and ?-glucosidase (K i Ê=Ê189.56) with characteristics typical of competitive and mixed type inhibitors, respectively. Docking simulations showed that prunin selectively inhibited PTP1B by targeting its active site and exhibited good binding affinity, with a docking score of -9Êkcal/mol. Furthermore, prunin exhibited dose-dependent inhibitory activity against ONOO - -mediated tyrosine nitration and stimulated glucose uptake by decreasing PTP1B expression level in insulin-resistant HepG2 cells. These results indicate that prunin has significant potential as a selective PTP1B inhibitor and may possess anti-diabetic properties by improving insulin resistance.